Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Eshima

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 1992
Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearanceA Taylor, P Corrigan, D Eshima, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 1992
Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studiesM Stabin, A Taylor, D Eshima, et al.
Contributions to Nephrology|January 1, 1990
Preliminary results comparing the extraction efficiencies of 131I-OIH and 99mTc-MAG3 in rat models of ischemia, renal artery stenosis, and ciclosporin toxicityA Taylor, J Greene, D Eshima, et al.
Seminars in Nuclear Medicine|February 3, 2000
Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerationsD Eshima, T Fauconnier, L Eshima, et al.
Radiology|February 1, 1987
Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal functionA Taylor, D Eshima, P E Christian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1986
Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacementA R Fritzberg, S Kasina, D Eshima, et al.
Journal of Medicinal Chemistry|October 1, 1986
Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticalsS Kasina, A R Fritzberg, D L Johnson, et al.
Nuclear Medicine and Biology|January 1, 1995
A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adultsC D Russell, A T Taylor, E V Dubovsky, et al.
Journal of Pharmaceutical Sciences|December 1, 1984
Comparison of 99mTc-N-pyridoxyl-5-methyltryptophan and 99mTc-N-(3-bromo-2,4,6-trimethylacetanilide)-iminodiace tate as hepatobiliary radiopharmaceuticals in ratsA R Fritzberg, D C Bloedow, D Eshima, et al.
Contributions to Nephrology|January 1, 1987
Preliminary evaluation of 99mTc mercaptoacetyltriglycine as a replacement for 131I OIHA Taylor, D Eshima, A R Fritzberg, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 11, 1992
Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearanceA Taylor, P Corrigan, D Eshima, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 1992
Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studiesM Stabin, A Taylor, D Eshima, et al.
Contributions to Nephrology|January 1, 1990
Preliminary results comparing the extraction efficiencies of 131I-OIH and 99mTc-MAG3 in rat models of ischemia, renal artery stenosis, and ciclosporin toxicityA Taylor, J Greene, D Eshima, et al.
Seminars in Nuclear Medicine|February 3, 2000
Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerationsD Eshima, T Fauconnier, L Eshima, et al.
Radiology|February 1, 1987
Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal functionA Taylor, D Eshima, P E Christian, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1986
Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacementA R Fritzberg, S Kasina, D Eshima, et al.
Journal of Medicinal Chemistry|October 1, 1986
Tissue distribution properties of technetium-99m-diamide-dimercaptide complexes and potential use as renal radiopharmaceuticalsS Kasina, A R Fritzberg, D L Johnson, et al.
Nuclear Medicine and Biology|January 1, 1995
A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adultsC D Russell, A T Taylor, E V Dubovsky, et al.
Journal of Pharmaceutical Sciences|December 1, 1984
Comparison of 99mTc-N-pyridoxyl-5-methyltryptophan and 99mTc-N-(3-bromo-2,4,6-trimethylacetanilide)-iminodiace tate as hepatobiliary radiopharmaceuticals in ratsA R Fritzberg, D C Bloedow, D Eshima, et al.
Contributions to Nephrology|January 1, 1987
Preliminary evaluation of 99mTc mercaptoacetyltriglycine as a replacement for 131I OIHA Taylor, D Eshima, A R Fritzberg, et al.
Pageof 4